Clinical Trial Update: Experimental PfSPZ Vaccine in Adults Without Malaria [Phase 1]

View source ↗

Summary

Phase 1 trial of the PfSPZ malaria vaccine in adults without malaria has completed, with the sponsor focusing on malaria prevention and immunity.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Malaria

Drugs mentioned

• PfSPZ Vaccine (Plasmodium falciparum sporozoite vaccine)

Snippet

Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) | Conditions: Malaria, Prevention and Control | Phase 1 | Status: COMPLETED